Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Politics : Stockman Scott's Political Debate Porch -- Ignore unavailable to you. Want to Upgrade?

To: Karen Lawrence who wrote (35557)	1/19/2004 11:56:57 AM
From: lurqer	Read Replies (1) \| Respond to of 89467

The Brits had to learn the hard way, but they are far ahead of us now. Action Urged to Stop Human 'Mad Cow' in UK Blood In a letter published in the British Medical Journal, a senior member of the UK's Medical Research Council calls for urgent action to prevent the spread of variant Creutzfeldt-Jakob disease (vCJD) -- the human form of mad cow disease -- through blood transfusions. Last month, UK health secretary John Reid announced the first case of vCJD that is believed to have to have occurred through blood donation. In light of this event, Dr. Sheila M. Bird, a statistician with the MRC, emphasizes that "we now need to take steps" to spell out the rights and responsibilities of people who have received blood and blood products that were possibly contaminated with vCJD, as well as those of the rest of the population. In her letter, Dr. Bird outlines several steps that can be taken to prevent further human-to-human spread of vCJD: --Anyone with suspected CJD should be reported to a national surveillance unit and then be cross-checked against a list of recipients who may have received vCJD-contaminated blood. --Use of blood products and other tissues from donors suspected of having CJD should stop immediately. --To prevent further transmission, before a definitive diagnosis is made, recipients of blood potentially contaminated with vCJD should be notified immediately of this risk. --Careful follow-up is needed for at-risk recipients who have undergone surgery in order to identify the extended network of at-risk subjects. --Counseling is needed for subjects in the at-risk network to help them assess their own risk and further reduce the risk of human-to-human spread. Until more is known about bloodborne transmission, she concludes, "we must hope for the best and protect against the worst." reuters.com lurqer